Unicycive Therapeutics, Inc.
NASDAQ:UNCYBiotechnology
-$0.24 today
- Market cap
- $104.19M
- Beta
- 1.73
- P/E (TTM)
- -40.8
- EPS (TTM)
- -$0.17
Volume 1.39M
Average 0.65M
UNCY Short-term Investments
Marketable securities and deposits the company expects to convert to cash within a year.
Unicycive Therapeutics, Inc.NASDAQ: UNCY
Short-term Investments · Q1 FY2026 · quarter ended Mar 2026
Short-term investments remains negative
Q1 FY2026 short-term investments was $17.22M, compared with $0 a year earlier.
Context
- Short-term investments amounted to 26.7% of total assets at the end of Q1 FY2026, up 26.7 pp from a year earlier.
- Short-term investments increased in 1 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
Sources:Balance SheetText generated from reported figures; not investment advice.
Short-term Investments history
USD · from the balance sheet
- Latest · FY2025
- 12.07M USD
- Year-over-year change
- —
| Period | Period end | Short-term Investments | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 12.07M | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Short-term Investments vs competitors
How UNCY compares with its peers on the latest reported figures
- Peers report in different currencies, so short-term investments is compared through growth and share of total assets rather than absolute size.
- Short-term investments amounts to 26.7% of total assets for UNCY, versus a peer median of 0.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $224.19M USD | +765.2% | -14.4% | 95.3% | |
ACRVAcrivon Therapeutics, Inc. Common Stock | Mar 2026 | $63.67M USD | -42.4% | -7.8% | 59.0% |
| Mar 2026 | $54.42M USD | -50.1% | -17.3% | 56.4% | |
| Mar 2026 | $17.22M USD | — | — | 26.7% | |
| Mar 2026 | $10.28M USD | -22.4% | -41.4% | 5.7% | |
| Mar 2026 | $0 USD | — | — | 0.0% | |
| Mar 2026 | $0 USD | — | — | 0.0% | |
CBUSCibus, Inc. | Mar 2026 | $0 USD | — | — | 0.0% |
HYFTMindWalk Holdings Corp. | Jan 2026 | CA$0 CAD | — | — | 0.0% |
| Mar 2026 | $0 USD | — | — | 0.0% | |
| Peer median (excluding UNCY) | — | -32.4% | -15.9% | 0.0% | |
Competitors are the stored peer set for UNCY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Unicycive Therapeutics, Inc.
NASDAQ:UNCY
Intrinsic Alpha fair value
Locked
Current Price
$3.57
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.